
Cipla Limited has informed the Exchange regarding a press release dated May 24, 2021, titled "Roche s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India".
Filed with NSE · · 5 pages · English

Cipla Limited has informed the Exchange regarding a press release dated May 24, 2021, titled "Roche s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India".
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla